Media Release: The Institute of Cancer Research, London Hormone therapy is used to slow the progression of advanced prostate cancer, but cancers often develop resistance and continue to grow Research reveals that patients with higher levels of heat shock proteins have worse outcomes Targeting these proteins with the ICR-discovered drug NXP800, currently in clinical trials […]
